focinvez Drug Patent Profile
✉ Email this page to a colleague
When do Focinvez patents expire, and what generic alternatives are available?
Focinvez is a drug marketed by Steriscience and is included in one NDA. There is one patent protecting this drug.
This drug has two patent family members in two countries.
The generic ingredient in FOCINVEZ is fosaprepitant dimeglumine. There are eleven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the fosaprepitant dimeglumine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Focinvez
A generic version of focinvez was approved as fosaprepitant dimeglumine by FRESENIUS KABI USA on June 9th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for focinvez?
- What are the global sales for focinvez?
- What is Average Wholesale Price for focinvez?
Summary for focinvez
International Patents: | 2 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
What excipients (inactive ingredients) are in focinvez? | focinvez excipients list |
DailyMed Link: | focinvez at DailyMed |
![focinvez drug patent expirations Drug patent expirations by year for focinvez](/p/graph/s/t/focinvez-patent-expirations.png)
US Patents and Regulatory Information for focinvez
focinvez is protected by one US patents.
Patents protecting focinvez
Compositions of fosaprepitant and methods of preparation
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Steriscience | FOCINVEZ | fosaprepitant dimeglumine | SOLUTION;INTRAVENOUS | 216686-001 | Aug 22, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for focinvez
See the table below for patents covering focinvez around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 4223297 | ADMINISTRATION ET DOSAGE DE DIAMINOPHÉNOTHIAZINES (ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES) | ⤷ Sign Up |
European Patent Office | 4335517 | ADMINISTRATION ET DOSAGE DE DIAMINOPHÉNOTHIAZINES (ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES) | ⤷ Sign Up |
Japan | 7073330 | ⤷ Sign Up | |
Spain | 2946165 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for focinvez
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0748320 | SPC/GB08/021 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: FOSAPREPITANT AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR THE BIS(N-METHYL-D-GLUCAMINE)SALT; REGISTERED: UK EU/1/07/437/001 20080111; UK EU/1/07/437/002 20080111 |
0748320 | 08C0019 | France | ⤷ Sign Up | PRODUCT NAME: FOSAPREPITANT DIMEGLUMINE; REGISTRATION NO/DATE: EU/1/07/437/001 20080111 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |